HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$1.14
Day range
$1.10 - $1.22
Year range
$0.83 - $2.11
Market cap
106.36M USD
Avg Volume
619.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.63M | 9.62% |
Net income | -25.18M | -16.70% |
Net profit margin | — | — |
Earnings per share | -0.25 | 47.92% |
EBITDA | -25.60M | -9.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.67M | -23.58% |
Total assets | 40.87M | -24.74% |
Total liabilities | 22.44M | -11.55% |
Total equity | 18.43M | — |
Shares outstanding | 90.15M | — |
Price to book | 5.70 | — |
Return on assets | -121.32% | — |
Return on capital | -208.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -25.18M | -16.70% |
Cash from operations | -22.96M | -63.71% |
Cash from investing | -3.00K | 98.18% |
Cash from financing | 77.00K | -87.25% |
Net change in cash | -23.40M | -79.82% |
Free cash flow | -14.68M | -125.26% |
About
CEO
Founded
May 2003
Website
Employees
91
